Stocks Comparison
LifeMD vs Oncology Institute: revenue, profit, margins and growth compared
LifeMD brought in $194.1M of revenue in fiscal 2025, Oncology Institute $502.7M in fiscal 2025. Revenue changed by +25.3% at LifeMD and +27.8% at Oncology Institute on the year before, so Oncology Institute grew faster. LifeMD kept 7.4% of its revenue as net profit, Oncology Institute -12.1%. Free cash flow was $6.4M at LifeMD and -$27.8M at Oncology Institute.
Side by side, latest fiscal year
| LFMD | TOI | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $194.1M | $502.7M |
| Revenue growth | +25.3% | +27.8% |
| Net income | $14.4M | -$60.6M |
| Net margin | 7.4% | -12.1% |
| Free cash flow | $6.4M | -$27.8M |
| Free cash flow margin | 3.3% | -5.5% |
| Earnings per share (diluted) | $0.25 | -$0.54 |
| Cash | $36.8M | $33.6M |
| Debt | n/a | $77.4M |
| Price to earnings | 11.7 | n/a |
| Market value | $141.2M | $522.8M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #272 of 742 · Health care | #204 of 742 · Health care |
Over the years
Questions about LifeMD and Oncology Institute
Which is bigger by revenue, LifeMD or Oncology Institute?
Oncology Institute is bigger by revenue: $502.7M in fiscal 2025, against $194.1M for LifeMD in fiscal 2025.
Which keeps more of its revenue as profit, LifeMD or Oncology Institute?
LifeMD had a net margin of 7.4% in fiscal 2025; Oncology Institute had -12.1% in fiscal 2025.
Which grew revenue faster, LifeMD or Oncology Institute?
In their latest fiscal years revenue changed by +25.3% at LifeMD and +27.8% at Oncology Institute.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.